Federal Register / Vol. 73, No. 200 / Wednesday, October 15, 2008 / Notices 61091 

Investigatory material compiled solely 

for the purpose of determining 

suitability, eligibility, or qualifications 

for federal civilian employment, 

military service, federal contracts, or 

access to classified information may be 

exempt pursuant to 5 U.S.C. 552a(k)(5), 

but only to the extent that such material 

would reveal the identity of a 

confidential source. 

An exemption rule for this record 

system has been promulgated in 

accordance with the requirements of 5 

U.S.C. 553(b)(1), (2), and (3), (c) and (e) 

and published in 32 CFR part 312. For 

additional information contact the 

system manager. 

[FR Doc. E8–24436 Filed 10–14–08; 8:45 am] 

BILLING CODE 5001–06–P 

DEPARTMENT OF DEFENSE 

Department of the Army 

Notice of Availability of a Novel 

Dendrimer Based Detection 

Technology for Exclusive, Partially 

Exclusive or Non-exclusive Licenses 

AGENCY: Department of the Army, DOD. 

ACTION: Notice of availability. 

SUMMARY: The Department of the Army 

announces the general availability of 

exclusive, partially exclusive or nonexclusive licenses relative to a novel 

dendrimer technology as described in 

United States Patent #6,716,450 entitled 

‘‘Enhancing Protein Activity Through 

Nanoencapsulation’’, Yin, et al., issued 

April 6, 2004. Licenses shall comply 

with 35 U.S.C. 209 and 37 CFR 404. 

FOR FURTHER INFORMATION CONTACT: 

Michael D. Rausa, U.S. Army Research 

Laboratory, Office of Research and 

Technology Applications, ATTN: 

AMSRD–ARL–DP–P/Bldg. 434, 

Aberdeen Proving Ground, MD 21005– 

5425, Telephone: (410) 278–5028. 

SUPPLEMENTARY INFORMATION: None. 

Brenda S. Bowen, 

Army Federal Register Liaison Officer. 

[FR Doc. E8–24512 Filed 10–14–08; 8:45 am] 

BILLING CODE 3710–08–P 

DEPARTMENT OF DEFENSE 

Department of the Army 

Notice of Intent To Grant an Exclusive 

License to ANP Technologies, Inc. 

AGENCY: Department of the Army, DOD. 

ACTION: Notice. 

SUMMARY: In compliance with 37 CFR 

404 et seq., the Department of the Army 

hereby gives notice of its intent to grant 

to ANP Technologies, Inc., 824 

Interchange Boulevard, Newark, DE 

19711, an exclusive license relative to 

United States Patent #6,716,450 entitled 

‘‘Enhancing Protein Activity Through 

Nanoencapsulation’’, Yin, et al., issued 

April 6, 2004. Anyone wishing to object 

to the granting of this license has 15 

days from the date of this notice to file 

written objections along with 

supporting evidence, if any. 

FOR FURTHER INFORMATION CONTACT: 

Michael D. Rausa, U.S. Army Research 

Laboratory, Office of Research and 

Technology Applications, ATTN: 

AMSRD–ARL–DP–P/Bldg. 434, 

Aberdeen Proving Ground, MD 21005– 

5425, Telephone: (410) 278–5028. 

SUPPLEMENTARY INFORMATION: None. 

Brenda S. Bowen, 

Army Federal Register Liaison Officer. 

[FR Doc. E8–24510 Filed 10–14–08; 8:45 am] 

BILLING CODE 3710–08–P 

DEPARTMENT OF DEFENSE 

Department of the Army 

Availability for Non-Exclusive, 

Exclusive, or Partially Exclusive 

Licensing of U.S. Provisional Patent 

Application Concerning Intraoral 

Measurement of Saliva Osmolarity to 

Measure Hydration Status 

AGENCY: Department of the Army, DoD. 

ACTION: Notice. 

SUMMARY: In accordance with 37 CFR 

404.6 and 404.7, announcement is made 

of the availability for licensing of the 

invention set forth in U.S. Provisional 

Patent Application Serial No. 61/ 

096,941 entitled ‘‘Intraoral 

Measurement of Saliva Osmolarity to 

Measure Hydration Status,’’ filed 

September 15, 2008. The United States 

Government, as represented by the 

Secretary of the Army, has rights in this 

invention. 

ADDRESSES: Commander, U.S. Army 

Medical Research and Materiel 

Command, ATTN: Command Judge 

Advocate, MCMR–JA, 504 Scott Street, 

Fort Detrick, Frederick, MD 21702– 

5012. 

FOR FURTHER INFORMATION CONTACT: For 

patent issues, Ms. Elizabeth Arwine, 

Patent Attorney, (301) 619–7808. For 

licensing issues, Dr. Paul Mele, Office of 

Research & Technology Assessment, 

(301) 619–6664, both at telefax (301) 

619–5034. 

SUPPLEMENTARY INFORMATION: The 

invention comprises a rapid, noninvasive method that uses saliva to 

determine and/or monitor a subject’s 

hydration level for diagnostic, 

treatment, and prophylactic purposes. 

By determining/monitoring the 

hydration status of a subject, preventive 

measures may be applied to prevent 

heat injuries and deaths. 

Brenda S. Bowen, 

Army Federal Register Liaison Officer. 

[FR Doc. E8–24497 Filed 10–14–08; 8:45 am] 

BILLING CODE 3710–08–P 

DEPARTMENT OF DEFENSE 

Department of the Army 

Availability for Non-Exclusive, 

Exclusive, or Partially Exclusive 

Licensing of U.S. Provisional Patent 

Application Concerning Method and 

Kit for Detecting Adenovirus Serotype 

14 Virus 

AGENCY: Department of the Army, DoD. 

ACTION: Notice. 

SUMMARY: In accordance with 37 CFR 

404.6 and 404.7, announcement is made 

of the availability for licensing of the 

invention set forth in U.S. Provisional 

Patent Application Serial No. 61/ 

058,598 entitled ‘‘Method and Kit for 

Detecting Adenovirus Serotype 14 

Virus,’’ filed June 4, 2008. The United 

States Government, as represented by 

the Secretary of the Army, has rights in 

this invention. 

ADDRESSES: Commander, U.S. Army 

Medical Research and Materiel 

Command, ATTN: Command Judge 

Advocate, MCMR–JA, 504 Scott Street, 

Fort Detrick, Frederick, MD 21702– 

5012. 

FOR FURTHER INFORMATION CONTACT: For 

patent issues, Ms. Elizabeth Arwine, 

Patent Attorney, (301) 619–7808. For 

licensing issues, Dr. Paul Mele, Office of 

Research & Technology Assessment, 

(301) 619–6664, both at telefax (301) 

619–5034. 

SUPPLEMENTARY INFORMATION: 

Adenovirus type 14 (Ad14) is an 

emerging pathogen that can cause life 

threatening diseases and large 

outbreaks. To improve the capability of 

the laboratory for diagnosing AD14 

infection and to prepare for possible 

outbreak, a real-time PCR assay targeting 

a unique sequence in the hexon region 

of the adenovirus genome is disclosed. 

Brenda S. Bowen, 

Army Federal Register Liaison Officer. 

[FR Doc. E8–24488 Filed 10–14–08; 8:45 am] 

BILLING CODE 3710–08–P 


jlentini on PROD1PC65 with NOTICES